isoniazid has been researched along with mefloquine hydrochloride in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Gerena, L; Milhous, WK; Opsenica, D; Pocsfalvi, G; Solaja, BA; Terzić, N; Tinant, B | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Franzblau, SG; Kozikowski, AP; Lilienkampf, A; Mao, J; Wan, B; Wang, Y | 1 |
Franzblau, SG; Kozikowski, AP; Lilienkampf, A; Pieroni, M; Wan, B; Wang, Y | 1 |
Franzblau, SG; He, R; Mao, J; Pak, D; Wan, B; Wang, Y; Yuan, H | 1 |
Adhikari, AV; Chowdhury, IH; Eswaran, S; Pal, NK; Thomas, KD | 1 |
Barry, CE; Dartois, V | 1 |
Chinthanom, P; Choeyklin, R; Fujii, R; Isaka, M; Kawashima, K; Mori, S; Rachtawee, P; Sappan, M; Srichomthong, K; Thummarukcharoen, T | 1 |
Chanthaket, R; Chinthanom, P; Isaka, M; Kongsaeree, P; Luangsa-ard, JJ; Prabpai, S; Sappan, M | 1 |
1 review(s) available for isoniazid and mefloquine hydrochloride
Article | Year |
---|---|
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Lung; Mycobacterium tuberculosis; Tuberculosis | 2013 |
8 other study(ies) available for isoniazid and mefloquine hydrochloride
Article | Year |
---|---|
Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Chlorocebus aethiops; Crystallography, X-Ray; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization; Spiro Compounds; Steroids; Structure-Activity Relationship; Vero Cells | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Isoxazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Vero Cells | 2009 |
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Design; Drug Resistance, Bacterial; Esters; Isoxazoles; Mycobacterium tuberculosis; Structure-Activity Relationship; Vero Cells | 2010 |
Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs.
Topics: Antitubercular Agents; Carboxylic Acids; Esters; Humans; Isoxazoles; Mefloquine; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prodrugs | 2010 |
New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties.
Topics: Antitubercular Agents; Bacteria; Crystallography, X-Ray; Microbial Sensitivity Tests; Quinolines | 2010 |
Highly Modified Lanostane Triterpenes from the Wood-Rot Basidiomycete
Topics: Carbon-13 Magnetic Resonance Spectroscopy; Fruiting Bodies, Fungal; Molecular Structure; Mycelium; Plasmodium falciparum; Polyporaceae; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Triterpenes; Wood | 2020 |
Lanostane and hopane triterpenes from the entomopathogenic fungus Hypocrella sp. BCC 14524.
Topics: Animals; Antimalarials; Antineoplastic Agents; Antitubercular Agents; Chlorocebus aethiops; Crystallography, X-Ray; Drug Resistance; Drug Screening Assays, Antitumor; Hypocreales; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Plasmodium falciparum; Stereoisomerism; Thailand; Triterpenes; Vero Cells | 2011 |